Clinical Laboratory Tests Market Growth 2022-2028: Growing Geriatric Population and Increasing Molecular, Pathological, and Immunological Tests are Expected to Bolster Market Growth

The global clinical laboratory tests market size is expected to reach USD 327.4 billion by 2028 at a CAGR of 7.3%, according to the latest report by Reports and Data. Rising prevalence of chronic and acute diseases globally, growing geriatric populace worldwide, increasing health awareness among people, and escalating need for early and accurate disease diagnosis are key factors expected to propel the global market growth. In addition, rising prevalence of target diseases, such as tuberculosis and diabetes, and cardiovascular disorders, growing awareness about regular body profiling, and increasing demand for molecular, pathological, and immunological testing are expected to further stimulate revenue growth. Strict government norms regarding clinical laboratory testing create further opportunities for the growth of the global clinical laboratory tests market.

Clinical laboratory tests refer to various medical tests performed in a laboratory to gain information about the health condition of a patient by using their blood or urine samples. These tests aid in the accurate diagnosis and prognosis of patients’ medical condition. Principal areas of clinical laboratory testing include clinical microbiology, clinical chemistry, hematology, DNA testing, and reproductive biology tests. Some of the commonly used clinical laboratory tests are Complete Blood Count (CBC), comprehensive metabolic panel, basic metabolic panel, liver panel, lipid panel, HbA1c, HGB/HCT, urinalysis, and thyroid stimulating hormone. Increasing government and private investments to develop advanced laboratory testing procedures, rapid adoption of highly advanced clinical diagnostic techniques, and increasing patient-centric approaches toward management of chronic and viral diseases are other significant factors expected to drive market growth. 

Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/4024

Key Highlights of the Report:

  • Based on test type, the basic metabolic tests segment is expected to dominate the global market in terms of market share over the forecast period. This segment’s growth is primarily attributed to rising prevalence of lifestyle-induced diseases such as cardiovascular disorders and growing health awareness among people globally.
  • Based on stand-alone laboratories, the service provider segment is expected to record fastest revenue growth rate of nearly 4.7% over the forecast period. Key factors responsible for this segment’s growth are rising prevalence of chronic and acute diseases, profoundly increasing patient pool, growing demand for technologically advanced laboratory equipment, and increasing need for rapid and accurate test results.
  • The North America clinical laboratory tests market is expected to be the leading regional market owing to factors such as growing geriatric population, rising volumes of laboratory tests, and increasing adoption of state-of-the-art clinical diagnostic procedures. The North America market growth is predicted to gain further momentum in the coming years due to the rapidly advancing healthcare infrastructure in the region.
  • Abbott Laboratories, Inc., Siemens Healthineers, Sonic Healthcare Ltd., Quest Diagnostics, Inc., Laboratory Corporation of America, LLC, Eurofins Scientific, OPKO Health, Inc., Charles River Laboratories International, Inc., Genoptix, Inc., NeoGenomics Laboratories Inc., Fresenius Medical Care, and Bioscientia Institut fr Medizinische Diagnostik GmbH are leading players in the global clinical laboratory tests market.

To know more about the report @ https://www.reportsanddata.com/report-detail/clinical-laboratory-tests-market

For the purpose of this report, the global clinical laboratory tests market has been segmented based on the test type, specialty, department, service provider, and region:

By Test Type (Revenue, USD Billion; 2018-2028)

  • Complete Blood Count (CBC)
  • HGB/HCT
  • Electrolytes Testing
  • BUN Creatinine Tests
  • Comprehensive Metabolic Panel
  • Basic Metabolic Panel
  • HbA1c Tests
  • Liver Panel
    • Bile Duct Obstruction
    • Autoimmune Disorders
    • Hepatitis
    • Liver Cancer
    • Liver Cirrhosis
    • Bone disease
    • Others
  • Lipid Panel
  • Renal Panel
  • Prothrombin Time
  • Thyroid Stimulating Hormone
  • Cultures
  • Others

By Specialty (Revenue, USD Billion; 2018-2028)

  • Clinical Chemistry Testing
    • Routine Chemistry Testing
    • Specialized Chemistry Testing
    • Endocrinology Chemistry Testing
    • Therapeutic Drug Monitoring (TDM) Testing
    • Others
  • Microbiology Testing
    • Infectious Disease Testing
    • Transplant Diagnostic Testing
    • Others
  • Genetic Testing
  • Cytology Testing
  • Immunology Testing
  • Hematology Testing
  • Drug of Abuse Testing

By Department (Revenue, USD Billion; 2018-2028)

  • Genetics
  • Hematology
  • Virology
  • Parasitology
  • Toxicology
  • Histopathology
  • Microbiology
  • Clinical Biochemistry
  • Urinalysis
  • Cytopathology
  • Immunology/Serology
  • Surgical Pathology
  • Others

By Service Provider (Revenue, USD Billion; 2018-2028)

  • Hospital-based Laboratories
  • Clinic-based Laboratories
  • Stand-alone Laboratories

Buy Premium Research Report @ https://www.reportsanddata.com/checkout-form/4024

By Region (Revenue, USD Billion; 2018-2028)

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
  • Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
  • Latin America (Brazil, Rest of LATAM)
  • Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Ask for Customized Research Report @ https://www.reportsanddata.com/request-customization-form/4024

Some points on how the report benefits stakeholders:

  • The reports include historical (2018–2020) and forecast (2021–2028) data points, revenues, and CAGR in table, figure, and chart formats, with detailed and qualitative, supporting written information for each.
  • Revenue break-up is provided for each segment in these formats for global, regional, and for each country in the respective region for each year between 2018 and 2028. 
  • The report contains insights regarding growth drivers, restraints, opportunities, trends, company profiles, strategic developments, expansion details, product launches, and various other aspects related to the market.
  • The report contains data and information on customers, competitors, vendors/distributors, and other players and in the global marketplace.
  • Market research analysis is vital for all crucial business strategies and can aid in numerous ways and to provide a clearer understanding about strategies being deployed by competitors, product launches, competitive analysis, technological advancements and various other factors that enhance sales of a firm or perhaps provide insights to focus on merger and acquisition as a strategy or enter into strategic agreements or joint ventures etc.
  • The report contains company profiles of the top companies operating in the market along with their respective revenue and operating segments, geographical reach, market footprint, headquarters, growth rates, recent developments, product /services, expansion strategies, investments in expansion, and more.

Explore Latest Trending Research Reports By Reports and Data's:

Hemolysis Agent for Blood Cell Analyzer Market By Product Type (Less than 500 ml, 500-2000 ml, 2000 ml), By Applications (Clinical, Analytical Research, Others), By End User (Hospitals, Diagnostic Centers, Pharmaceutical Companies) And Segment Forecasts, 2020-2028

Digestive Enzymes Market By Product Type (Carbohydrates, Protease, Lipase, Others), By Dosage Form (Tablets, Capsules, Powder, Liquids, Others), By Source Type (Animal-derived, Plant-derived, Fungi, Microbial, Others), By Application (Medical & Infant Nutrition, Sports Nutrition, Additional Supplements, Others), By Distribution Channel, and By Region, Forecast to 2028

Neuroleptics Market Size, Trends & Analysis, By Product (First Generation Drugs, Second Generation Drugs, Third Generation Drugs), By Disease (Schizophrenia, Bipolar Disorder, Dementia, Unipolar Depression, Others), By End-User (Hospital, Retail, Online), By Region, Segment Forecasts To 2028

DTaP Vaccine Market By Disease Type (Diphtheria, Tetanus, and Pertussis), by Product Type (Daptacel, Infanrix, Kinrix, Pediarix, Pentacel, Quaracel), By End-User (Hospitals, Clinics, Vaccination Centers), And Segment Forecasts To 2028

Insulin Pens Market Share, Size and Growth, By Product (Traditional insulin Pens and smart insulin Pens), By Usage (Prefilled Insulin Pens, Smart Insulin Pen Caps, Reusable Insulin Pens), By End-User And Segment Forecasts To 2028

About Reports and Data


Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs

Back to news